Basis of Presentation and Summary of Significant Accounting Policies, Contingent Consideration (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Contingent Consideration [Abstract]
Reduction in contingent consideration adjusted to carrying value of technology intangible asset	$ 0.0
TheraClear Corporation [Member]
Contingent Consideration [Abstract]
Risk free rate of return		3.80%
Revenue volatility		15.00%
Cost of equity		10.00%
Fair value of contingent consideration		$ 1.2
Reduction in contingent consideration adjusted to carrying value of technology intangible asset		$ (7.4)